NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT05438576,Screening for Pregnancy Related Heart Failure in Nigeria,https://clinicaltrials.gov/study/NCT05438576,,COMPLETED,This study will evaluate the effectiveness of an artificial intelligence-enabled ECG (AI-ECG) for cardiomyopathy detection in an obstetric population in Nigeria.,YES,Cardiomyopathy|Pregnancy Related,OTHER: Digital stethoscope electrocardiogram,"Left Ventricular Ejection Fraction (LVEF) <50%, Number of participants diagnosed with left ventricular ejection fraction (LVEF) \<50% by echocardiography during pregnancy or within 12 months postpartum., 18 months","Effectiveness of AI-ECG for Cardiomyopathy Detection in the Intervention Arm for Left Ventricular Ejection Fraction (LVEF) ≤ 35%, This is defined as a positive point-of-care AI prediction for LVEF ≤ 35% (maximum prediction across all stethoscope recording locations) confirmed with echocardiography, 18 months|Effectiveness AI-ECG for Cardiomyopathy Detection in the Intervention Arm in LVEF < 40%, This is defined as a positive point-of-care AI prediction for LVEF \< 40% (maximum prediction across all stethoscope recording locations) confirmed with echocardiography, 18 months|Effectiveness AI-ECG for Cardiomyopathy Detection in the Intervention Arm in LVEF < 45%, This is defined as a positive point-of-care AI prediction for LVEF \<45% (maximum prediction across all stethoscope recording locations) confirmed with echocardiography, 18 months|Effectiveness AI-ECG for Cardiomyopathy Detection in the Intervention Arm in LVEF < 50%, This is defined as a positive point-of-care AI prediction for LVEF \<50% (maximum prediction across all stethoscope recording locations) confirmed with echocardiography, 18 months","Composite Adverse Cardiovascular Events, The number of subjects to experience composite cardiovascular events with include any of the following: diastolic heart failure, gestational hypertension, pre-eclampsia, eclampsia, valvular heart disease, atrial arrhythmias and sustained ventricular arrhythmias., 18 months|Echocardiography Utilization, Determine the impact of an AI-ECG on echocardiography utilization, 18 months|Effectiveness of AI Point of Care Tools for Cardiomyopathy Detection in the Intervention Arm, Develop and evaluate the diagnostic performance of an AI-enhanced point of care screening tool, 18 months",Mayo Clinic,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Center for Advancing Translational Sciences (NCATS)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),FEMALE,ADULT,NA,1232,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING,22-000539|K12AR084222|UL1TR002377,2022-08-15,2024-05-15,2024-05-15,2022-06-30,2025-05-16,2025-05-16,"Rasheed Shekoni Specialist Hospital, Dutse, Jigawa State, Nigeria|University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria|Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria|University College Hospital, Ibadan, Oyo State, Nigeria|Aminu Kano Teaching Hospital, Kano, Nigeria|Lagos University Teaching Hospital, Lagos, Nigeria","Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/76/NCT05438576/Prot_SAP_000.pdf"
